Royal Bank of Canada’s Avidity Biosciences RNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $13.8M | Sell |
|
|||||
|
2025
Q2 | $17.2M | Buy |
|
|||||
|
2025
Q1 | $1.31M | Buy |
|
|||||
|
2024
Q4 | $932K | Sell |
|
|||||
|
2024
Q3 | $2.37M | Buy |
|
|||||
|
2024
Q2 | $413K | Buy |
|
|||||
|
2024
Q1 | $80K | Sell |
|
|||||
|
2023
Q4 | $217K | Buy |
|
|||||
|
2023
Q3 | $77K | Buy |
|
|||||
|
2023
Q2 | $85K | Buy |
|
|||||
|
2023
Q1 | $67K | Sell |
|
|||||
|
2022
Q4 | $161K | Buy |
|
|||||
|
2022
Q3 | $20K | Buy |
|
|||||
|
2022
Q2 | $5K | Sell |
|
|||||
|
2022
Q1 | $52K | Sell |
|
|||||
|
2021
Q4 | $189K | Buy |
|
|||||
|
2021
Q3 | $192K | Buy |
|
|||||
|
2021
Q2 | $169K | Sell |
|
|||||
|
2021
Q1 | $155K | Buy |
|
|||||
|
2020
Q4 | $85K | Buy |
|